Abeona Therapeutics (ABEO) News Today → How Biden has already won 2024 (From Porter & Company) (Ad) Free ABEO Stock Alerts $4.27 -0.01 (-0.23%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 2:40 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOJune 5, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOJune 3, 2024 | globenewswire.comAbeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 1, 2024 | americanbankingnews.comAbeona Therapeutics Inc (NASDAQ:ABEO) Short Interest UpdateJune 1, 2024 | americanbankingnews.comAbeona Therapeutics (NASDAQ:ABEO) Receives New Coverage from Analysts at Stifel NicolausMay 31, 2024 | americanbankingnews.comZacks Small Cap Brokers Boost Earnings Estimates for Abeona Therapeutics Inc (NASDAQ:ABEO)May 30, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOMay 30, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Coverage Initiated by Analysts at Stifel NicolausStifel Nicolaus began coverage on shares of Abeona Therapeutics in a research report on Thursday. They set a "buy" rating and a $21.00 target price for the company.May 30, 2024 | marketbeat.comQ2 2024 EPS Estimates for Abeona Therapeutics Inc (NASDAQ:ABEO) Lifted by AnalystAbeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Zacks Small Cap raised their Q2 2024 earnings per share estimates for Abeona Therapeutics in a research report issued on Tuesday, May 28th. Zacks Small Cap analyst D. Bautz now forecasts that the biopharmaceutical company will post earnings ofMay 28, 2024 | msn.comABEO: BLA Resubmission in 2H24May 28, 2024 | globenewswire.comAbeona Therapeutics to Present at the Jefferies Global Healthcare ConferenceMay 27, 2024 | marketbeat.comAIGH Capital Management LLC Has $3.95 Million Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO)AIGH Capital Management LLC decreased its holdings in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 30.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 787,769 shares of the biopharmaceutical company's stockMay 23, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOMay 22, 2024 | uk.investing.comAbeona Therapeutics director buys $51,798 in company stockMay 21, 2024 | insidertrades.comLeila Alland Acquires 11,000 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) StockMay 20, 2024 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) Director Leila Alland Purchases 11,000 SharesAbeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) Director Leila Alland purchased 11,000 shares of the stock in a transaction that occurred on Thursday, May 16th. The stock was acquired at an average cost of $4.71 per share, with a total value of $51,810.00. Following the completion of the acquisition, the director now directly owns 82,857 shares of the company's stock, valued at $390,256.47. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.May 16, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOMay 16, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Price Target Cut to $21.00 by Analysts at Cantor FitzgeraldCantor Fitzgerald decreased their target price on shares of Abeona Therapeutics from $28.00 to $21.00 and set an "overweight" rating on the stock in a research report on Thursday.May 16, 2024 | finance.yahoo.comQ1 2024 Abeona Therapeutics Inc Earnings CallMay 16, 2024 | finance.yahoo.comAbeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...May 15, 2024 | washingtonpost.comAbeona Therapeutics: Q1 Earnings SnapshotMay 15, 2024 | investorplace.comABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024May 15, 2024 | globenewswire.comAbeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate ProgressMay 7, 2024 | globenewswire.comAbeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 6, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOMay 3, 2024 | marketwatch.comAbeona Therapeutics Shares Rise After Underwritten Offering Gets PricedMay 3, 2024 | markets.businessinsider.comAbeona Prices Offering Of $75 Mln Common Stock, WarrantsMay 3, 2024 | finance.yahoo.comAbeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsMay 2, 2024 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of InvestorsMay 1, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of InvestorsApril 30, 2024 | insidertrades.comAbeona Therapeutics Inc (NASDAQ:ABEO) Director Buys $24,764.00 in StockApril 29, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of InvestorsApril 29, 2024 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) Director Faith L. Charles Purchases 7,550 SharesAbeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) Director Faith L. Charles bought 7,550 shares of Abeona Therapeutics stock in a transaction on Friday, April 26th. The shares were acquired at an average price of $3.28 per share, for a total transaction of $24,764.00. Following the completion of the acquisition, the director now owns 78,323 shares of the company's stock, valued at approximately $256,899.44. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.April 27, 2024 | insidertrades.comInsider Buying: Abeona Therapeutics Inc (NASDAQ:ABEO) CFO Acquires 5,608 Shares of StockApril 27, 2024 | insidertrades.comAbeona Therapeutics Inc (NASDAQ:ABEO) SVP Brendan M. O'malley Acquires 8,600 SharesApril 26, 2024 | marketbeat.comFY2024 EPS Estimates for Abeona Therapeutics Inc Cut by Analyst (NASDAQ:ABEO)Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Research analysts at Cantor Fitzgerald reduced their FY2024 earnings per share estimates for Abeona Therapeutics in a report released on Wednesday, April 24th. Cantor Fitzgerald analyst K. Kluska now expects that the biopharmaceutical companyApril 25, 2024 | finance.yahoo.comABEO: Receives CRL Based on Need for More CMC Information…April 23, 2024 | seekingalpha.comAbeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not LostApril 23, 2024 | finanznachrichten.deAbeona Therapeutics Inc.: Abeona Therapeutics Provides Regulatory Update on Pz-celApril 23, 2024 | msn.comFDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares SinkApril 23, 2024 | marketbeat.comCantor Fitzgerald Reaffirms Overweight Rating for Abeona Therapeutics (NASDAQ:ABEO)Cantor Fitzgerald reiterated an "overweight" rating and set a $36.00 target price on shares of Abeona Therapeutics in a research report on Tuesday.April 23, 2024 | investorplace.comWhy Is Abeona Therapeutics (ABEO) Stock Down 45% Today?April 22, 2024 | marketwatch.comAbeona Therapeutics Shares Down 53% After FDA Complete Response LetterApril 22, 2024 | reuters.comUS FDA declines to approve Abeona's skin disorder treatmentApril 22, 2024 | globenewswire.comAbeona Therapeutics Provides Regulatory Update on Pz-celApril 22, 2024 | marketbeat.comTrading was temporarily halted for "ABEO" at 04:04 PM with a stated reason of "News pending."April 15, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Upgraded by StockNews.com to "Hold"StockNews.com upgraded shares of Abeona Therapeutics from a "sell" rating to a "hold" rating in a report on Monday.April 1, 2024 | globenewswire.comAbeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 27, 2024 | finance.yahoo.comHere's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn SituationMarch 22, 2024 | marketbeat.comAnalysts Issue Forecasts for Abeona Therapeutics Inc's FY2024 Earnings (NASDAQ:ABEO)Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Analysts at Cantor Fitzgerald lowered their FY2024 earnings estimates for Abeona Therapeutics in a note issued to investors on Tuesday, March 19th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biopharmaceutical company will earn Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. ABEO Media Mentions By Week ABEO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABEO News Sentiment▼0.000.76▲Average Medical News Sentiment ABEO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABEO Articles This Week▼32▲ABEO Articles Average Week Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aclaris Therapeutics News Equillium News Lumos Pharma News AcelRx Pharmaceuticals News Voyager Therapeutics News Sage Therapeutics News Lyell Immunopharma News Dianthus Therapeutics News Silence Therapeutics News AnaptysBio News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABEO) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored